5 Healthcare Stocks to Watch in Light of Biden’s ‘60 Minutes’ Interview

4. Dynavax Technologies Corporation (NASDAQ:DVAX)

Number of Hedge Fund Holders: 18

Year-to-Date Performance: -24.21%

Dynavax Technologies Corporation (NASDAQ:DVAX) is a biotech company based in EmeryVille, California. It works to develop and commercialize novel vaccines in the US.

Roy Buchanan at JMP Securities initiated coverage of Dynavax Technologies Corporation (NASDAQ:DVAX) shares on September 27 with an Outperform rating. The analyst also placed a $22 price target on the stock.

Dynavax Technologies Corporation (NASDAQ:DVAX) fell 24.21% year-to-date and 11.04% in the past six months. However, the company’s operating cash flow growth rate year-over-year stands at 45.28%.

Out of 895 funds tracked in the second quarter, 18 funds were long Dynavax Technologies Corporation (NASDAQ:DVAX), with a total stake value of $206 million. In comparison, 22 funds were long the stock in the previous quarter, with a total stake value of $191 million.